hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10
Published July 1, 2026 · Recall initiated: June 2, 2026
Summary
FDA records drug Class III recall D-0619-2026, published July 1, 2026 and initiated June 2, 2026. Recalling firm: ANI Pharmaceuticals, Inc.; Status: Ongoing; Reported quantity: 6564 bottles; Lot: Lot S25133A. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of foreign substance
What to do
Voluntary: Firm initiated · Letter
Get an email if HYDROXYZINE HYDROCHLORIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROXYZINE HYDROCHLORIDE
- Manufacturer
- ANI Pharmaceuticals, Inc.
- Distributor
- Nationwide in the USA
- UPC
- 0370954912101
- Lot
- Lot S25133A
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATotal Parental Nutrition - Pediatric PN Patient-Specific TPN Bag, (patient specific), Rx#July 1, 2026
- FDAPReye Vitamin See Antioxidant Preservative Free Eye Drops, Distributed by: PReye, LLC, Golden, COJuly 1, 2026
- FDAHydrOXYzine HYDROCHLORIDE SYRUP (HydrOXYzine Hydrochloride Oral Solution, USP), 10 mg per 5 mL, Rx only,October 31, 2018
- FDAHydrOXYzine HCI Tablets USP 10 mg, 100 count bottles, Rx only. Mfd by KVK-TECH, INC, Newtown, PA 18940. NDCJanuary 29, 2014
- FDAHydrOXYzine HCI Tablets USP 25 mg, 100, 500, and 1000 count bottles, Rx only. Mfd by: KVK-TECH, INC, Newtown,January 29, 2014
- FDAHydrOXYzine HCI Tablets USP 50 mg, 100, 500, and 1000 count bottles, Rx only. Mfd by: KVK-TECH, INC, Newtown,January 29, 2014
Questions about this recall
Was hydrOXYzine Hydrochloride Oral Solution, USP, 10 mg/5 mL, 473 mL (1 Pint), Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC: 70954-912-10 recalled?
Yes. FDA published recall D-0619-2026 on July 1, 2026. Reported hazard: Presence of foreign substance
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROXYZINE HYDROCHLORIDE. UPC: 0370954912101.